Nurtec ODT (rimegepant) Letter of Medical Necessity
Nurtec ODT (rimegepant) is the only CGRP therapy approved for both acute and preventive migraine treatment. Prior authorization commonly requires documented triptan failure or contraindication and a migraine headache diary.
FDA-Approved Indications
- ● acute treatment of migraine
- ● preventive treatment of episodic migraine
Why Nurtec ODT Prior Authorization Gets Denied
The most common denial reasons across major payers:
- 1. Two triptan trials not documented (step therapy)
- 2. Headache diary or migraine frequency not on file
- 3. Dual acute + preventive use not justified
- 4. Quantity limit exceeded
What to Include in a Nurtec ODT Letter of Medical Necessity
Document migraine diagnosis, monthly migraine days, MIDAS or HIT-6 disability score, prior acute treatments (triptans, NSAIDs) with documented inadequate response or contraindication, and the clinical rationale for dual-use oral CGRP antagonism when requesting both acute and preventive coverage.
Key clinical evidence to cite:
- ✓ Study 301 (acute treatment)
- ✓ Study 305 (preventive every-other-day dosing)
- ✓ Long-term safety data
Relevant guidelines:
- 📖 AHS Position Statement on CGRP Therapies
- 📖 AAN Migraine Practice Guideline
Nurtec ODT Prior Authorization Criteria
Standard criteria across major US payers for Nurtec ODT. Specific criteria vary by plan — RxCheckUp tailors each LMN to your patient's exact payer policy.
Typical step therapy requirements:
- → Two triptan trials not documented (step therapy)
Required documentation:
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy history with dates, doses, and discontinuation reasons
- ✓ Specialist evaluation (where applicable)
- ✓ Baseline disease activity or biomarker results
- ✓ Clinical rationale citing FDA labeling or guidelines
Approval details:
Initial approval: typically 6 months. Renewal: 12 months with documented clinical response.
Payers Covering Nurtec ODT
RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:
Nurtec ODT Prior Authorization FAQ
Why was my Nurtec ODT prior authorization denied?
The most common denial reasons for Nurtec ODT are: Two triptan trials not documented (step therapy); Headache diary or migraine frequency not on file; Dual acute + preventive use not justified; Quantity limit exceeded.
What should a Nurtec ODT Letter of Medical Necessity include?
Document migraine diagnosis, monthly migraine days, MIDAS or HIT-6 disability score, prior acute treatments (triptans, NSAIDs) with documented inadequate response or contraindication, and the clinical rationale for dual-use oral CGRP antagonism when requesting both acute and preventive coverage.
Which payers cover Nurtec ODT?
Nurtec ODT is covered by major US payers including UnitedHealthcare, Aetna, Cigna, BCBS, Express Scripts, though formulary tier and prior authorization criteria vary.